Lv4
590 积分 2022-10-31 加入
Cancer statistics, 2023
4个月前
已完结
Distinct clinicopathologic characteristics of lung mucinous adenocarcinoma with KRAS mutation
4个月前
已完结
CD74–NRG1 Fusions in Lung Adenocarcinoma
5个月前
已完结
Growth pattern-based grading of pulmonary adenocarcinoma—Analysis of 534 cases with comparison between observers and survival analysis
5个月前
已完结
Clinical course of stage IV invasive mucinous adenocarcinoma of the lung
5个月前
已完结
Optimal Cutoff Points of CYFRA21-1 for Survival Prediction in Non-small Cell Lung Cancer Patients Based on Running Statistical Analysis
5个月前
已关闭
Serum tumor marker CYFRA 21-1 in the diagnostics of NSCLC lung cancer
5个月前
已关闭
[The importance of the tumor marker CYFRA 21-1 in patients with lung cancer after surgery or chemotherapy]
5个月前
已关闭
Toward personalized treatment approaches for non-small-cell lung cancer
5个月前
已完结
Disparities in 36 cancers across 185 countries: secondary analysis of global cancer statistics
5个月前
已完结
皖公网安备34019202002308
